Eli Lilly's New Antibody Treatment Bamlanivimib Approved for Emergency Use Against Early COVID-19

TUESDAY, Nov. 10, 2020 — Eli Lilly’s experimental antibody treatment for COVID-19 was given emergency approval by the U.S. and Food Administration on Monday.
The promising news came the same day that President-elect Joseph Biden called for all…
Source: Topamax